Publications by authors named "C Flamens"

Combined lung-liver transplantation is a rare life-saving procedure to treat concomitant end-stage lung and liver failure. In this report, we describe the first published case of single lung and liver transplantation in a cystic fibrosis patient who had previously undergone a pneumonectomy for the treatment of an infected and destroyed right lung. We detail the lung first, sequential transplant procedure and surgical difficulties due to mediastinal shift.

View Article and Find Full Text PDF

Objectives: Survival after heart transplantation is steadily improving but primary graft dysfunction (PGD) is still a leading cause of death. Medical management seems useful in mild or moderate PGD, whereas extracorporeal life support (ECLS) could be suggested for severe PGD refractory to conventional treatment. Our aim is to present the results of ECLS for PGD after heart transplantation at a single-centre experience.

View Article and Find Full Text PDF

Lung transplantation (LT) is now considered as an excellent treatment option for selected patients with end-stage pulmonary diseases, such as COPD, cystic fibrosis, idiopathic pulmonary fibrosis, and pulmonary arterial hypertension. The 2 goals of LT are to provide a survival benefit and to improve quality of life. The 3-step decision process leading to LT is discussed in this review.

View Article and Find Full Text PDF

We report a case of severe Legionnaires' disease (LD) complicated by a lung abscess in an immunocompetent patient who required ECMO therapy and thoracic surgery. The results of repeated Legionella quantitative real-time PCR performed on both sera and respiratory samples correlated with the LD severity and the poor clinical outcome. Moreover, the PCR allowed for the detection of Legionella DNA in the lung abscess specimen, which was negative when cultured for Legionella.

View Article and Find Full Text PDF
Article Synopsis
  • Septic shock, often complicated by acute kidney injury (AKI), is a major cause of death in critically ill patients, prompting the investigation of high-volume haemofiltration (HVHF) as a potential treatment.
  • The study was a clinical trial involving 140 patients with septic shock and AKI, comparing the effects of HVHF and standard-volume haemofiltration (SVHF) on 28-day mortality over a 96-hour period.
  • Results showed no significant difference in mortality rates between the HVHF group (37.9%) and the SVHF group (40.8%), leading to the conclusion that HVHF does not improve outcomes in these patients and is not recommended for treatment.
View Article and Find Full Text PDF